Kerala and West Bengal, two of the biggest states to have opposed the Goods and Services Tax (GST) borrowing plan, have opted for option 1 to meet the GST compensation shortfall.
Both the states will get Rs 10,197 crore through a special borrowing window to meet the GST compensation shortfall.
"Permission to raise additional Rs 11,309 crore through borrowings also issued to Kerala and West Bengal," the government said in a press release.
The states and union territories opting for option 1 would be getting the amount of shortfall arising out of GST implementation through a special borrowing window put in place by the Centre. The window has been operational from October 23 and the Centre has already borrowed Rs 24,000 crore on behalf of the states in four instalments and passed it on to those who had already opted for it. Kerala and West Bengal would receive funds raised through this window starting from the next round of borrowings.
Under the terms of option 1, besides getting the facility of a special window for borrowings to meet the shortfall arising out of GST implementation, states are also entitled to get unconditional permission to borrow the final instalment of 0.50 percent of gross state domestic product (GSDP) out of the 2 percent additional borrowings permitted by the Centre.
Frequently Asked Questions
A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.
There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.
Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
"This is over and above the special window of Rs 1.1 lakh crore... The Government of India has granted additional borrowing permission of Rs 4,522 crore to the state government of Kerala (0.5 percent of Kerala’s GSDP) and Rs 6,787 crore to the state government of West Bengal (0.5 percent of West Bengal’s GSDP)," the statement said.
“Some of the States are likely to approach SC against discriminatory and illegal action of Centre regarding GST Compensation. Kerala CM to chair a meeting of law, tax and finance departments and advocate general to take final decision on Kerala’s stance tomorrow afternoon,” Kerala finance minister Thomas Isaac had tweeted on October 15.
This was followed by the finance ministry announcing it would borrow Rs 1.1 lakh crore and give that amount as loan to states under a special borrowing window, rather than states do it on their own.